KK Shah Hospital

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0OH401016
  • NSEID:
  • BSEID: 544013
INR
40.00
0.00 (0.00%)
BSENSE

Nov 28

BSE+NSE Vol: 51000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

51.0 k (269.57%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

71.36%

How has been the historical performance of the KK Shah Hospital?

07-Jun-2025

For the fiscal year ending March 2024, KK Shah Hospital reported an operating income of Rs 6.88 crore and a net profit of Rs 0.61 crore, with total assets increasing to Rs 14.52 crore. The hospital demonstrated strong financial growth, reflected in rising shareholder equity and profitability metrics.

Answer:<BR>The historical performance of KK Shah Hospital for the year ending March 2024 shows a total operating income of Rs 6.88 crore, with a net profit of Rs 0.61 crore. The operating profit margin, excluding other income, stands at 8.72%, while the profit after tax margin is 8.87%. The earnings per share (EPS) is reported at Rs 0.9, with a diluted EPS of Rs 1.07. The company's total assets have increased to Rs 14.52 crore from Rs 5.61 crore in the previous year, and shareholder's funds have also risen significantly to Rs 14.09 crore from Rs 5.09 crore. <BR><BR>Breakdown:<BR>In the fiscal year ending March 2024, KK Shah Hospital achieved total operating income of Rs 6.88 crore, with no raw material or finished goods costs reported, leading to a total expenditure of Rs 6.28 crore. This resulted in an operating profit (PBDIT) of Rs 1.08 crore, after accounting for employee costs and other expenses. The profit before tax was Rs 0.70 crore, culminating in a profit after tax of Rs 0.61 crore. The balance sheet reflects a substantial increase in total assets to Rs 14.52 crore, driven by growth in non-current investments and reserves, while total liabilities remained stable with no long-term borrowings. The cash flow statement indicates a net cash outflow of Rs 1.00 crore, primarily due to investing activities, despite a positive cash inflow from financing activities. Overall, the hospital's financial metrics indicate a positive trajectory in revenue and profitability, alongside a solid increase in shareholder equity.

Read More

Who are the top shareholders of the KK Shah Hospital?

06-Jun-2025

The top shareholder of KK Shah Hospital is Kirti Kumar Shah, holding 20.19% of the shares. Individual investors own 24.54%, while Shreni Shares Limited is the largest public shareholder at 1.15%.

The top shareholders of KK Shah Hospital primarily consist of promoters, with Kirti Kumar Shah holding the largest share at 20.19%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors involved. Additionally, the highest public shareholder is Shreni Shares Limited, which holds 1.15%. Individual investors collectively own 24.54% of the shares.

Read More

how big is KK Shah Hospital?

06-Jun-2025

As of Jun 06, KK Shah Hospitals Ltd has a market capitalization of 30.00 Cr, with standalone net sales of 1.62 Cr and a net profit of 0.10 Cr for the latest quarter. As of Mar'24, the company reports shareholder's funds of 14.09 Cr and total assets of 14.52 Cr.

As of Jun 06, KK Shah Hospitals Ltd has a market capitalization of 30.00 Cr, categorizing it as a Micro Cap company.<BR><BR>As of Jun'23, the company reported standalone net sales of 1.62 Cr and a net profit of 0.10 Cr for the latest quarter.<BR><BR>As of Mar'24, the standalone balance sheet shows shareholder's funds of 14.09 Cr and total assets of 14.52 Cr.

Read More

What does KK Shah Hospital do?

06-Jun-2025

KK Shah Hospitals Ltd provides healthcare services and is classified as a micro-cap company with a market cap of Rs 33 Cr. It reported net sales of 2 Cr and a net profit of 0 Cr for June 2023.

Overview:<BR>KK Shah Hospitals Ltd is engaged in providing healthcare services and operates within the hospital industry, categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated on August 25, 2022, originally under the name "Jeevan Parv Healthcare Limited." It changed its name to "KK Shah Hospitals Limited" on November 30, 2022. The latest quarterly results reported net sales and net profit for June 2023.<BR><BR>Financial Snapshot:<BR>- Net Sales: 2 Cr (Quarterly Results - Jun 2023)<BR>- Net Profit: 0 Cr (Quarterly Results - Jun 2023)<BR>- Market-cap: Rs 33 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A<BR>- Industry P/E: 54<BR>- Dividend Yield: 1.14%<BR>- Debt Equity: -0.06<BR>- Return on Equity: -2.34%<BR>- Price to Book: 2.13<BR><BR>Contact Details:<BR>No Company Details Available.

Read More

Who are in the management team of KK Shah Hospital?

06-Jun-2025

As of March 2023, the management team of KK Shah Hospital includes Amit Shah (Chairman & Managing Director), Kirti Kumar Shah (Whole-time Director), Hansa Shah and Milli Shah (Executive Directors), and several Independent Directors: Achint Porwal, Gaurav Ajmera, Meetesh Gadia, and Sanjay Kumar Luniya, along with Saloni Badjatya as Company Secretary & Compliance Officer.

As of March 2023, the management team of KK Shah Hospital includes the following individuals:<BR><BR>1. Amit Shah - Chairman & Managing Director<BR>2. Kirti Kumar Shah - Whole-time Director<BR>3. Hansa Shah - Executive Director<BR>4. Milli Shah - Executive Director<BR>5. Achint Porwal - Independent Director<BR>6. Gaurav Ajmera - Independent Director<BR>7. Meetesh Gadia - Independent Director<BR>8. Sanjay Kumar Luniya - Independent Director<BR>9. Saloni Badjatya - Company Secretary & Compliance Officer<BR><BR>These members play various roles in the governance and operational management of the hospital.

Read More

When is the next results date for KK Shah Hospital?

06-Jun-2025

No Upcoming Board Meetings

Has KK Shah Hospital declared dividend?

06-Jun-2025

KK Shah Hospitals Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of August 16, 2024. The dividend yield is 1.14%, and total returns over various periods have shown modest performance, particularly in the short term.

KK Shah Hospitals Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 16 Aug 24<BR><BR>Dividend Yield: 1.14%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 2.83%, the dividend return was 0%, resulting in a total return of 2.83%.<BR><BR>For the 1-year period, the price return was 2.08%, the dividend return was 1.02%, leading to a total return of 3.1%.<BR><BR>Over the 2-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>In the 3-year period, both the price return and dividend return were 0%, leading to a total return of 0.0%.<BR><BR>For the 4-year period, there were no returns from price or dividends, resulting in a total return of 0.0%.<BR><BR>In the 5-year period, there was again no price return or dividend return, leading to a total return of 0.0%.<BR><BR>Overall, KK Shah Hospitals Ltd has declared a dividend, contributing to a modest yield, while the total returns over various periods show a mix of performance, with significant returns only in the shorter time frames.

Read More

Who are the peers of the KK Shah Hospital?

04-Jun-2025

KK Shah Hospital's peers include Max Healthcare, Apollo Hospitals, Fortis Health, and others. In terms of management risk, KK Shah Hospital has Below Average risk and a 1-year return of -4.23%, significantly lower than Soni Medicare's 124.83%.

Peers: The peers of KK Shah Hospital are Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Aster DM Health, Soni Medicare, Broach, and Nidan Laborator.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, and Global Health, while Average management risk is found at Fortis Health and Broach. Aster DM Health, Soni Medicare, Nidan Laborator, and KK Shah Hospital exhibit Below Average management risk. In terms of Growth, Excellent growth is seen at Max Healthcare and Apollo Hospitals, Good growth at Fortis Health and Narayana Hrudaya, while Aster DM Health shows Below Average growth, and KK Shah Hospital, Soni Medicare, and Nidan Laborator display Below Average growth. Capital Structure is Excellent for Max Healthcare and Global Health, Good for Fortis Health and KK Shah Hospital, Average for Apollo Hospitals and Broach, and Below Average for Aster DM Health, Soni Medicare, and Nidan Laborator.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Soni Medicare at 124.83%, while KK Shah Hospital has a 1-year return of -4.23%, which is significantly lower than Soni Medicare. The peer with the lowest 1-year return is Docmode Health, which has no data available. Additionally, Aster DM Health, KK Shah Hospital, Soni Medicare, Broach, Nidan Laborator, and Docmode Health all have negative six-month returns.

Read More

Is KK Shah Hospital overvalued or undervalued?

09-Jun-2025

As of January 2, 2025, KK Shah Hospital is considered overvalued and risky due to negative earnings, poor return on equity, and unfavorable valuation metrics compared to its peers, alongside a lagging stock performance relative to the Sensex.

As of 2 January 2025, KK Shah Hospital's valuation grade has moved from fair to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued based on its current metrics, with a PE ratio of -33.36, an EV to EBITDA of 32.56, and a Price to Book Value of 2.37. These ratios suggest that the market is pricing the stock at a premium despite its negative earnings and poor return on equity of -2.34%.<BR><BR>In comparison to its peers, KK Shah Hospital's valuation stands out unfavorably. For instance, Max Healthcare Institute Ltd. has a PE ratio of 100.29, while Apollo Hospitals Enterprise Ltd. shows a PE of 69.03, both indicating a much stronger market position. Additionally, the company's recent stock performance has lagged behind the Sensex, with a 1-year return of -7.08% compared to the Sensex's 7.53%. Overall, KK Shah Hospital is considered overvalued relative to its financial performance and peer group.

Read More

What is the technical trend for KK Shah Hospital?

09-Jun-2025

As of June 6, 2025, KK Shah Hospital's technical trend is mildly bullish, supported by the weekly MACD and KST, although caution is advised due to mildly bearish daily moving averages and mixed signals from other indicators.

As of 6 June 2025, the technical trend for KK Shah Hospital has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, supported by a mildly bullish KST and Dow Theory. However, the daily moving averages remain mildly bearish, which suggests some caution. The Bollinger Bands are bullish on the weekly timeframe, while the monthly indicators show no significant signals. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and KST, despite mixed signals from other indicators.

Read More

Which are the latest news on KK Shah Hospital?

04-Dec-2025

Why is KK Shah Hospital falling/rising?

05-Dec-2025

As of 04-Dec, KK Shah Hospitals Ltd's stock price is stable at Rs 40.00, with a recent 4.44% increase over the past week. However, it has declined by 7.62% in the last month and 16.49% over the past year, indicating ongoing challenges despite today's positive performance.

As of 04-Dec, KK Shah Hospitals Ltd's stock price is currently stable at Rs 40.00, showing no change from the previous trading session. Despite this stability, the stock has experienced a mixed performance over different periods. In the last week, it has risen by 4.44%, outperforming the Sensex, which declined by 0.53%. This recent uptick is notable as the stock opened with a gain of 4.44% today and reached an intraday high of Rs 40.<BR><BR>However, the stock has faced challenges over longer periods. Over the past month, it has fallen by 7.62%, and year-to-date, it is down 5.21%. Additionally, the stock has shown a significant decline of 16.49% over the past year, while the Sensex has increased by 5.32% in the same timeframe. The stock is also trading below its moving averages across various time frames, indicating a bearish trend.<BR><BR>Investor participation appears to be declining, as evidenced by a 28.57% drop in delivery volume compared to the 5-day average. This decline in trading activity could contribute to the stock's overall performance challenges. Despite today's positive performance, the combination of longer-term declines and reduced investor engagement suggests that the stock may face ongoing pressure.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 26 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

-2.52%

stock-summary
Price to Book

1.99

Revenue and Profits:
Net Sales:
2 Cr
(Quarterly Results - Jun 2023)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.09%
0%
-9.09%
6 Months
-9.09%
0%
-9.09%
1 Year
-7.19%
0%
-7.19%
2 Years
-51.69%
0.63%
-51.06%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.5 per share ex-dividend date: Aug-16-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
Announcements stock-summary

Financial Results For The Half Year Ended As On 30Th September 2025.

10-Nov-2025 | Source : BSE

Financial Results for the half year ended as on 30th September 2025.

Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results

10-Nov-2025 | Source : BSE

Outcome of the Board Meeting held on 10th November 2025 for approval of Unaudited Financial Results and other agenda items of the company.

Board Meeting Intimation for Intimation Of The Board Meeting Of The Company To Be Held On November 10 2025.

04-Nov-2025 | Source : BSE

KK Shah Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve 1.Unaudited financial results along with Limited Review Report of Company for the half year ended on September 30 2025. 2. Any other business with permission of Chair if any.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

KK Shah Hospitals Ltd has declared 5% dividend, ex-date: 16 Aug 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
30.80%
EBIT Growth (5y)
-110.00%
EBIT to Interest (avg)
-0.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.68
Tax Ratio
0
Dividend Payout Ratio
56.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-6.95%
ROE (avg)
5.71%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
0
Price to Book Value
2.08
EV to EBIT
-26.44
EV to EBITDA
26.44
EV to Capital Employed
2.15
EV to Sales
2.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.15%
ROE (Latest)
-2.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kirti Kumar Shah (20.19%)

Highest Public shareholder

Shreni Shares Limited (1.15%)

Individual Investors Holdings

24.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.62",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.22",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.10",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.58%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -3.02% vs 23.33% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 54.29% vs -289.19% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.82",
          "val2": "4.97",
          "chgp": "-3.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.66",
          "val2": "-0.20",
          "chgp": "430.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.32",
          "val2": "-0.70",
          "chgp": "54.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.69%",
          "val2": "-4.02%",
          "chgp": "17.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Jun 2023 is 13.98% vs 51.07% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Jun 2023 is -146.81% vs 46.87% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.44",
          "val2": "5.65",
          "chgp": "13.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.88",
          "val2": "0.55",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "0.47",
          "chgp": "-146.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.66%",
          "val2": "9.73%",
          "chgp": "3.93%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.00",
          "val2": "6.88",
          "chgp": "30.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.13",
          "val2": "0.60",
          "chgp": "-78.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.33",
          "val2": "0.61",
          "chgp": "-154.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.44%",
          "val2": "8.72%",
          "chgp": "-7.28%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'23 - QoQstock-summary
Jun'23
Change(%)
Net Sales
1.62
NA
NA
Operating Profit (PBDIT) excl Other Income
0.22
NA
NA
Interest
0.00
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
0.10
NA
NA
Operating Profit Margin (Excl OI)
13.58%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Mar'25
Change(%)
Net Sales
4.82
4.97
-3.02%
Operating Profit (PBDIT) excl Other Income
0.66
-0.20
430.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.32
-0.70
54.29%
Operating Profit Margin (Excl OI)
13.69%
-4.02%
17.71%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -3.02% vs 23.33% in Mar 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 54.29% vs -289.19% in Mar 2025

Nine Monthly Results Snapshot (Standalone) - Jun'23stock-summary
Jun'23
Jun'23
Change(%)
Net Sales
6.44
5.65
13.98%
Operating Profit (PBDIT) excl Other Income
0.88
0.55
60.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.22
0.47
-146.81%
Operating Profit Margin (Excl OI)
13.66%
9.73%
3.93%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Jun 2023 is 13.98% vs 51.07% in Jun 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Jun 2023 is -146.81% vs 46.87% in Jun 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
9.00
6.88
30.81%
Operating Profit (PBDIT) excl Other Income
0.13
0.60
-78.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.33
0.61
-154.10%
Operating Profit Margin (Excl OI)
1.44%
8.72%
-7.28%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About KK Shah Hospitals Ltd stock-summary
stock-summary
KK Shah Hospitals Ltd
Micro Cap
Hospital
KK Shah Hospitals Limited was incorporated under the name style of "Jeevan Parv Healthcare Limited" on August 25, 2022 by the Central Registration Center, Manesar. Subsequently, the Company changed its name from "Jeevan Parv Healthcare Limited" to "KK Shah Hospitals Limited" and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh. The Company is engaged in the providing healthcare services. The Promoter, Dr.
Company Coordinates stock-summary
Icon
No Company Details Available